Market revenue in 2023 | USD 267.2 million |
Market revenue in 2030 | USD 454.0 million |
Growth rate | 7.9% (CAGR from 2023 to 2030) |
Largest segment | Coronary stents |
Fastest growing segment | Accessory Devices |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Intravascular Imaging Catheters and Pressure Guidewires, Coronary Stents, PTCA Balloon Catheters, Accessory Devices |
Key market players worldwide | Abbott Laboratories, Medtronic PLC, Boston Scientific Corp, Koninklijke Philips NV, Cardinal Health Inc, Terumo Corp, Teleflex Inc, B. Braun, Biosensors, BIOTRONIK, Asahi Intecc Co Ltd, Cook Medical, Merit Medical Systems Inc, Haemonetics Corp, Vascular Solutions, Zeon Corp, Alvimedica, Meril Life, Medinol |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to interventional cardiology devices market will help companies and investors design strategic landscapes.
Coronary stents was the largest segment with a revenue share of 51.61% in 2023. Horizon Databook has segmented the Australia interventional cardiology devices market based on intravascular imaging catheters and pressure guidewires, coronary stents, ptca balloon catheters, accessory devices covering the revenue growth of each sub-segment from 2018 to 2030.
In Australia, the increasing adoption of PCI procedures drives the interventional cardiology devices market. Government initiatives and healthcare infrastructure investments contribute to the expansion of the market, facilitating improved access to innovative medical technologies and enhancing patient outcomes in cardiovascular care across the country.
In Australia, growth of interventional cardiology devices presents both opportunities and challenges for healthcare professionals. With advancements in technology and increasing demand for minimally invasive procedures, there is a growing need for specialized training programs tailored to the Australian healthcare landscape.
These training programs aim to prepare healthcare providers with the necessary skills and expertise to effectively utilize interventional cardiology devices. They focus on educating professionals on the latest techniques, procedures, and technologies, ensuring they are proficient in delivering high-quality care to patients.
Horizon Databook provides a detailed overview of country-level data and insights on the Australia interventional cardiology devices market , including forecasts for subscribers. This country databook contains high-level insights into Australia interventional cardiology devices market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account